OncoMethylome Sciences Reinforces U.S. Presence with Key Executive Appointments
Dr. Jan Groen, Chief Executive Officer of OncoMethylome, said: "With extensive experience in the molecular diagnostics space in the U.S., Melissa and Chris will be instrumental in expanding our presence in the U.S. market. They will both play a key role in developing and executing our new strategy, providing invaluable knowledge of the regulatory and commercialization processes. "
Melissa Thompson has more than 25 years of experience in the pharmaceutical, medical device, and molecular diagnostics industries. She has provided extensive consultative services in diagnostics to leading companies such as Johnson & Johnson, Wyeth, Inverness, and Affymetrix, as well start-ups like Signature Genomic Laboratories, Prognomix, Allegro Diagnostics, and ExonHit Therapeutics. She has fostered multiple products through U.S. Food and Drug Administration approval, and has additional background in clinical research and clinical trial design. Melissa Thompson holds a Ph.D. in Organizational Management from Concordia University and an MBA from Temple University, Philadelphia, PA.
Christopher Thibodeau brings over 15 years of sales, marketing and commercial leadership experience in the diagnostics arena. As Vice President Commercial Operations, he is responsible for developing and executing OncoMethylome's key strategic sales & marketing and business development initiatives. Prior to joining OncoMethylome he served as Senior Director of Marketing at Agendia Inc., Vice President of Sales and Marketing for Numira Biosciences, National Director of Sales US LABS (an industry leader in cancer diagnostic and genomic testing services); and a number of sales and marketing management roles at Ventana Medical. Chris Thibodeau holds a BSc degree from the East Stroudsburg University in Pennsylvania and studied French at the Faculté des Lettres in Nancy, France.
Most read news
Other news from the department people
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.